Avalide

Type: Product
Name: Avalide
First reported Mar 28 2014 - Updated Mar 28 2014 - 1 reports

Patent expiration, stagnant R&D spend seriously affect blockbuster sales of big pharma during 2007-2013

Patent expiration of several blockbusters and limited success in launching new molecules during the last few years are the two critical factors that  impacted the revenues of the top international pharmaceutical companies during the period 2007-2013. ... [Published PharmaBiz - Mar 28 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 1 reports

Pharma's winners and losers in 2013

Roche, and Amgen rose up the rankings of the The exclusive industry ranking is centred around global pharmaceutical sales (including generics) for the 25 largest companies in the industry and based on figures provided by GlobalData.The 2013 ranking, which ... [Published PMLive - Mar 13 2014]

Quotes

"Some companies have proven to be more defensive than others, notably those involved in the production of biologic medicines, such as Roche and Amgen" he added

More Content

All (5) | News (3) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (2) | Press Releases (0)
sort by: Date | Relevance
Patent expiration, stagnant R&D spend seriously... [Published PharmaBiz - Mar 28 2014]
Pharma's winners and losers in 2013 [Published PMLive - Mar 13 2014]
Natural Remedies for Blood Pressure | “High Blo... [Published PRWeb - Sep 08 2013]
Fact Sheet for Bristol Myers Squibb Co [Published Able2Act - Jan 02 2008]
Fact Sheet for Bristol Myers Squibb Co [Published Able2Act - Jan 02 2008]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.